Matas Logo

Matas

ISIN

DK0060497295

Ticker

MATAS

Sector

Consumer Staples

Sub-Industry

Drug Retail

Country

Denmark

Year Founded

1949

About Matas

Company Description

Matas is one of Denmark’s most recognised and most reputable brands. Originally owned by a network of independent materialists, Matas dates back to 1949. Today, Matas is a listed company with more than 2,500 employees, the majority of whom work in one of the Group’s 263 Matas stores.

Matas generates annual revenue of more than DKK 3.5 billion from sales of beauty, health and wellbeing products. Almost 20% of revenue is generated by the Group’s private labels, including the iconic Matas Stripes products, the organic Matas Natur range, luxury skincare from Plaisir and the natural makeup brand Nilens Jord.

Most of the Group's customers still prefer to shop at physical stores, of which a large number have undergone significant renovation since the beginning of 2019. At the same time as the physical stores are being renovated and renewed, sales via matas.dk and the Group’s other webshops are recording strong growth as customers increasingly choose to do part of their shopping online.

Headcount

2,500

Served Area

Denmark

Headquarters

Rørmosevej 1
3450, Allerød
Denmark

Financial statements

Download as Excel
Line item in (dkk) 01.04.2020 01.04.2021 01.04.2022 01.07.2022 01.10.2022 01.04.2023 01.07.2023 01.10.2023
Assets N/A 6,143,100,000.00 6,055,300,000.00 6,054,700,000.00 6,111,200,000.00 6,280,200,000.00 6,378,000,000.00 8,624,900,000.00
Noncurrent Assets N/A 5,158,900,000.00 5,026,300,000.00 4,986,800,000.00 4,983,100,000.00 5,201,700,000.00 5,181,200,000.00 6,383,100,000.00
Property Plant And Equipment N/A 897,300,000.00 723,400,000.00 N/A N/A N/A N/A N/A
Land And Buildings N/A 90,800,000.00 86,600,000.00 88,800,000.00 89,000,000.00 87,500,000.00 86,100,000.00 93,400,000.00
Construction In Progress N/A 0.00 9,600,000.00 11,600,000.00 51,700,000.00 59,700,000.00 63,900,000.00 206,700,000.00
Other Property Plant And Equipment N/A 103,200,000.00 86,700,000.00 82,800,000.00 74,800,000.00 65,200,000.00 61,900,000.00 79,300,000.00
Goodwill N/A 3,930,600,000.00 3,993,600,000.00 3,993,600,000.00 3,999,400,000.00 3,999,400,000.00 3,999,400,000.00 4,093,900,000.00
Brand Names N/A 143,600,000.00 67,800,000.00 65,300,000.00 62,900,000.00 58,100,000.00 55,700,000.00 188,700,000.00
Other Intangible Assets N/A 130,300,000.00 186,800,000.00 191,700,000.00 203,600,000.00 235,800,000.00 237,500,000.00 403,300,000.00
Investments In Associates Accounted For Using Equity Method N/A 12,400,000.00 7,300,000.00 7,500,000.00 1,200,000.00 1,400,000.00 700,000.00 900,000.00
Deferred Tax Assets N/A N/A N/A N/A 0.00 0.00 N/A 8,600,000.00
Noncurrent Investments Other Than Investments Accounted For Using Equity Method N/A 600,000.00 600,000.00 600,000.00 600,000.00 700,000.00 600,000.00 700,000.00
Longterm Deposits N/A 44,100,000.00 46,800,000.00 47,000,000.00 47,500,000.00 44,300,000.00 47,600,000.00 47,600,000.00
Other Noncurrent Assets N/A 57,100,000.00 54,700,000.00 55,100,000.00 49,300,000.00 46,400,000.00 48,900,000.00 57,800,000.00
Current Assets N/A 984,200,000.00 1,029,000,000.00 1,067,900,000.00 1,128,100,000.00 1,078,500,000.00 1,196,800,000.00 2,241,800,000.00
Inventories N/A 866,700,000.00 890,100,000.00 928,900,000.00 999,300,000.00 911,800,000.00 1,006,200,000.00 1,755,300,000.00
Current Trade Receivables N/A 15,200,000.00 26,600,000.00 30,900,000.00 33,800,000.00 43,700,000.00 64,700,000.00 97,600,000.00
Current Prepayments N/A N/A N/A 32,500,000.00 30,900,000.00 40,800,000.00 42,000,000.00 76,300,000.00
Other Current Receivables N/A 4,600,000.00 7,100,000.00 3,200,000.00 7,800,000.00 24,900,000.00 12,600,000.00 48,700,000.00
Current Tax Assets Current N/A 19,400,000.00 45,500,000.00 26,300,000.00 13,100,000.00 20,600,000.00 4,800,000.00 2,400,000.00
Cash and cash equivalents 106,600,000.00 40,700,000.00 28,200,000.00 46,100,000.00 43,200,000.00 36,700,000.00 66,500,000.00 261,500,000.00
Equity And Liabilities N/A 6,143,100,000.00 6,055,300,000.00 6,054,700,000.00 6,111,200,000.00 6,280,200,000.00 6,378,000,000.00 8,624,900,000.00
Equity 2,764,000,000.00 3,038,900,000.00 3,152,300,000.00 3,147,000,000.00 3,195,800,000.00 3,363,100,000.00 3,337,400,000.00 3,364,400,000.00
Issued Capital N/A 95,700,000.00 95,700,000.00 95,700,000.00 95,700,000.00 95,700,000.00 95,700,000.00 95,700,000.00
Retained Earnings N/A 2,870,200,000.00 3,055,200,000.00 3,094,000,000.00 3,142,800,000.00 3,233,500,000.00 3,261,800,000.00 3,267,200,000.00
Treasury Shares N/A 2,600,000.00 76,000,000.00 43,500,000.00 43,500,000.00 43,500,000.00 20,900,000.00 20,900,000.00
Equity Attributable To Owners Of Parent N/A 3,038,900,000.00 3,151,800,000.00 3,146,500,000.00 3,195,300,000.00 3,362,600,000.00 3,336,900,000.00 3,363,900,000.00
Noncontrolling Interests N/A 0.00 500,000.00 500,000.00 500,000.00 500,000.00 500,000.00 500,000.00
Liabilities N/A 3,104,200,000.00 2,903,000,000.00 2,907,700,000.00 2,915,400,000.00 2,917,100,000.00 3,040,600,000.00 5,260,500,000.00
Noncurrent Liabilities N/A 781,600,000.00 1,598,100,000.00 1,563,100,000.00 1,625,400,000.00 1,620,100,000.00 1,596,300,000.00 3,004,000,000.00
Noncurrent Provisions N/A 27,700,000.00 28,000,000.00 28,100,000.00 28,100,000.00 28,000,000.00 28,000,000.00 28,000,000.00
Other Noncurrent Payables N/A 59,200,000.00 37,700,000.00 38,700,000.00 43,100,000.00 13,000,000.00 13,500,000.00 11,900,000.00
Deferred Tax Liabilities N/A 199,200,000.00 192,800,000.00 193,200,000.00 193,100,000.00 198,800,000.00 198,100,000.00 239,100,000.00
Longterm Borrowings N/A 0.00 996,100,000.00 996,500,000.00 1,096,900,000.00 917,700,000.00 918,100,000.00 1,848,300,000.00
Current Liabilities N/A 2,322,600,000.00 1,304,900,000.00 1,344,600,000.00 1,290,000,000.00 1,297,000,000.00 1,444,300,000.00 2,256,500,000.00
Trade And Other Current Payables To Trade Suppliers N/A 692,400,000.00 662,900,000.00 680,100,000.00 757,700,000.00 634,100,000.00 846,800,000.00 1,136,900,000.00
Current Advances N/A 158,600,000.00 154,500,000.00 153,200,000.00 150,300,000.00 161,400,000.00 159,200,000.00 191,400,000.00
Other Current Payables N/A 199,200,000.00 150,100,000.00 130,700,000.00 116,200,000.00 202,700,000.00 169,500,000.00 388,400,000.00
Current Dividend Payables N/A N/A N/A 75,900,000.00 N/A 0.00 76,200,000.00 N/A
Line item in (dkk) 01.04.2020/
01.04.2021
01.04.2021/
01.04.2022
01.04.2022/
01.07.2022
01.04.2022/
01.10.2022
01.07.2022/
01.10.2022
01.04.2023/
01.07.2023
01.04.2023/
01.10.2023
01.07.2023/
01.10.2023
Revenue 4,163,600,000.00 4,344,200,000.00 1,053,500,000.00 2,042,700,000.00 989,200,000.00 1,150,000,000.00 2,435,400,000.00 1,285,400,000.00
Employee Benefits Expense 751,900,000.00 824,100,000.00 201,900,000.00 398,400,000.00 196,500,000.00 214,900,000.00 497,200,000.00 282,300,000.00
Depreciation Amortisation And Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss 407,600,000.00 421,300,000.00 89,100,000.00 175,800,000.00 86,700,000.00 91,100,000.00 204,200,000.00 113,100,000.00
Profit Loss From Operating Activities 380,400,000.00 388,300,000.00 97,600,000.00 170,900,000.00 73,300,000.00 88,700,000.00 113,700,000.00 25,000,000.00
Finance Income 17,500,000.00 5,300,000.00 0.00 0.00 0.00 0.00 2,700,000.00 2,700,000.00
Finance Costs 45,200,000.00 37,900,000.00 9,200,000.00 17,200,000.00 8,000,000.00 23,400,000.00 47,600,000.00 24,200,000.00
Profit Loss Before Tax 353,400,000.00 351,100,000.00 88,600,000.00 148,600,000.00 60,000,000.00 65,400,000.00 69,000,000.00 3,600,000.00
Income Tax Expense Continuing Operations 84,400,000.00 74,600,000.00 19,500,000.00 32,800,000.00 13,300,000.00 16,400,000.00 18,400,000.00 2,000,000.00
Profit (loss) 269,000,000.00 276,500,000.00 69,100,000.00 115,800,000.00 46,700,000.00 49,000,000.00 50,600,000.00 1,600,000.00
Line item in (dkk) 01.04.2020 01.04.2021 01.04.2022 01.07.2022 01.10.2022 01.04.2023 01.07.2023 01.10.2023
Profit (loss) N/A 269,000,000.00 276,500,000.00 69,100,000.00 46,700,000.00 N/A 49,000,000.00 1,600,000.00
Adjustments For Finance Costs N/A 45,200,000.00 37,900,000.00 9,200,000.00 8,000,000.00 N/A 23,400,000.00 24,200,000.00
Adjustments For Undistributed Profits Of Associates N/A 700,000.00 -4,600,000.00 200,000.00 -5,300,000.00 N/A 100,000.00 100,000.00
Other Adjustments For Noncash Items N/A 5,200,000.00 -13,500,000.00 1,500,000.00 2,200,000.00 N/A 2,000,000.00 3,400,000.00
Cash Flows From Used In Operations N/A 1,018,600,000.00 614,500,000.00 144,500,000.00 145,700,000.00 N/A 251,500,000.00 -73,900,000.00
Interest Received Classified As Operating Activities N/A 17,400,000.00 5,200,000.00 0.00 0.00 N/A 0.00 2,700,000.00
Cash Flows From Used In Operating Activities N/A 952,000,000.00 510,500,000.00 144,500,000.00 145,700,000.00 N/A 251,500,000.00 -71,200,000.00
Cash Flows From Losing Control Of Subsidiaries Or Other Businesses Classified As Investing Activities N/A 0.00 400,000.00 N/A N/A N/A N/A N/A
Cash Flows Used In Obtaining Control Of Subsidiaries Or Other Businesses Classified As Investing Activities N/A 24,000,000.00 48,600,000.00 N/A 1,500,000.00 N/A N/A 617,100,000.00
Purchase Of Property Plant And Equipment Classified As Investing Activities N/A 50,500,000.00 50,500,000.00 13,800,000.00 47,900,000.00 N/A 15,700,000.00 50,900,000.00
Purchase Of Intangible Assets Classified As Investing Activities N/A 97,900,000.00 132,900,000.00 32,100,000.00 36,100,000.00 N/A 34,900,000.00 39,400,000.00
Cash Flows From Used In Investing Activities N/A -177,900,000.00 -231,600,000.00 -45,900,000.00 -85,500,000.00 N/A -50,600,000.00 -707,400,000.00
Payments To Acquire Or Redeem Entitys Shares N/A 0.00 75,100,000.00 N/A N/A N/A N/A N/A
Proceeds From Borrowings Classified As Financing Activities N/A 0.00 763,500,000.00 N/A 0.00 N/A N/A 1,121,300,000.00
Repayments Of Borrowings Classified As Financing Activities N/A 725,000,000.00 708,400,000.00 N/A -62,600,000.00 N/A N/A 0.00
Payments Of Lease Liabilities Classified As Financing Activities N/A 168,800,000.00 167,700,000.00 43,100,000.00 42,300,000.00 N/A 38,800,000.00 51,600,000.00
Dividends Paid Classified As Financing Activities N/A 0.00 76,600,000.00 N/A 76,600,000.00 N/A N/A 76,600,000.00
Interest Paid Classified As Financing Activities N/A 39,900,000.00 27,100,000.00 7,700,000.00 6,900,000.00 N/A 21,900,000.00 21,600,000.00
Cash Flows From Used In Financing Activities N/A -840,000,000.00 -291,400,000.00 -80,700,000.00 -63,200,000.00 N/A -171,100,000.00 971,500,000.00
Effect Of Exchange Rate Changes On Cash And Cash Equivalents N/A N/A N/A N/A 0.00 N/A N/A 2,200,000.00
Increase (decrease) in cash and cash equivalents after effect of exchange rate changes N/A -65,900,000.00 -12,500,000.00 17,900,000.00 -2,900,000.00 N/A 29,800,000.00 192,800,000.00
Cash and cash equivalents 106,600,000.00 40,700,000.00 28,200,000.00 46,100,000.00 43,200,000.00 36,700,000.00 66,500,000.00 261,500,000.00

Please note that some sums might not add up.

Filings & Publications

  • Consolidated Report 2024 - Q4 English 🇬🇧 Published: 04.07.2024
  • Consolidated Report 2023 - Q4 English 🇬🇧 Published: 04.07.2023
  • Consolidated Report 2022 - Q4 Danish 🇩🇰

Capital Markets Information

ISIN

DK0060497295

LEI

2138004PXX8LWGHGL872

Sub-Industry

Drug Retail

Listed Stock Exchange

Nasdaq Copenhagen

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.